Next Article in Journal
3,5-T2-an Endogenous Thyroid Hormone Metabolite as Promising Lead Substance in Anti-Steatotic Drug Development?
Previous Article in Journal
Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis—Preliminary Data
Previous Article in Special Issue
HBM4EU Chromates Study: Urinary Metabolomics Study of Workers Exposed to Hexavalent Chromium
 
 
Article

Article Versions Notes

Metabolites 2022, 12(7), 581; https://doi.org/10.3390/metabo12070581
Action Date Notes Link
article xml file uploaded 23 June 2022 06:33 CEST Original file -
article xml uploaded. 23 June 2022 06:33 CEST Update -
article pdf uploaded. 23 June 2022 06:33 CEST Version of Record https://www.mdpi.com/2218-1989/12/7/581/pdf-vor
article supplementary file uploaded. 23 June 2022 06:33 CEST - https://www.mdpi.com/2218-1989/12/7/581#supplementary
article html file updated 23 June 2022 06:35 CEST Original file -
article xml file uploaded 24 June 2022 08:45 CEST Update -
article xml uploaded. 24 June 2022 08:45 CEST Update -
article pdf uploaded. 24 June 2022 08:45 CEST Updated version of record https://www.mdpi.com/2218-1989/12/7/581/pdf-vor
article html file updated 24 June 2022 08:46 CEST Update -
article xml file uploaded 7 July 2022 05:18 CEST Update -
article xml uploaded. 7 July 2022 05:18 CEST Update https://www.mdpi.com/2218-1989/12/7/581/xml
article pdf uploaded. 7 July 2022 05:18 CEST Updated version of record https://www.mdpi.com/2218-1989/12/7/581/pdf
article html file updated 7 July 2022 05:19 CEST Update -
article html file updated 11 July 2022 03:26 CEST Update -
article supplementary file uploaded. 11 July 2022 03:28 CEST - https://www.mdpi.com/2218-1989/12/7/581#supplementary
article html file updated 12 August 2022 21:55 CEST Update https://www.mdpi.com/2218-1989/12/7/581/html
Back to TopTop